Healthcare provider profile · identity verified

Sonia Bagga, MD

Internal Medicine · WORCESTER, MA · NPI 1265497127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	107
Omeprazole	Omeprazole	202	68
Amlodipine Besylate	Amlodipine Besylate	193	55
Levothyroxine Sodium	Levothyroxine Sodium	190	51
Rosuvastatin Calcium	Rosuvastatin Calcium	131	44
Lisinopril	Lisinopril	120	42
Pantoprazole Sodium	Pantoprazole Sodium	104	26
Losartan Potassium	Losartan Potassium	102	26
Famotidine	Famotidine	98	27
Sertraline Hcl	Sertraline Hcl	89	23
Hydrochlorothiazide	Hydrochlorothiazide	87	31
Metoprolol Succinate	Metoprolol Succinate	86	22
Fluticasone Propionate	Fluticasone Propionate	79	40
Gabapentin	Gabapentin	79	36
Metformin Hcl	Metformin Hcl	64	16
Metformin Hcl Er	Metformin Hcl	63	19
Furosemide	Furosemide	58	17
Eliquis	Apixaban	55	11
Albuterol Sulfate Hfa	Albuterol Sulfate	51	21
Pravastatin Sodium	Pravastatin Sodium	50	14
Valsartan	Valsartan	49	19
Diclofenac Sodium	Diclofenac Sodium	45	17
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Alendronate Sodium	Alendronate Sodium	40	14
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Glipizide Er	Glipizide	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Atenolol	Atenolol	36	12
Duloxetine Hcl	Duloxetine Hcl	35	14
Ketoconazole	Ketoconazole	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Topiramate	Topiramate	34	suppressed
Simvastatin	Simvastatin	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	12
Jardiance	Empagliflozin	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Trazodone Hcl	Trazodone Hcl	27	12
Verapamil Er	Verapamil Hcl	27	suppressed
Baclofen	Baclofen	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Pregabalin	Pregabalin	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Clonazepam	Clonazepam	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Ozempic	Semaglutide	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Trospium Chloride	Trospium Chloride	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Carvedilol	Carvedilol	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	19	suppressed
Lorazepam	Lorazepam	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Prednisone	Prednisone	16	12
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Bupropion Xl	Bupropion Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Naproxen	Naproxen	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error